Wikipedia -WSS

Wikipedia

author：knowledge 2025-10-02 19:21:05 - browse：2754

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Robert F. Kennedy is pitching centrism on health, even on abortion

leisure time

knowledge

WSS

For Medicare Advantage, Democrats want stronger protections around AI

Patient advocates sound warning on FDA proposal on salt intake

KalVista pill reduced swelling 'attacks' caused by genetic disease

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

KalVista pill reduced swelling 'attacks' caused by genetic disease

KalVista pill reduced swelling 'attacks' caused by genetic disease

Wikipedia

Wikipedia

explore

Wildfire smoke exposes gaps in outdoor worker protections

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Affirmative action in medical school literally saved lives

The Readout: Gilead, Bernie Sanders, and other pharma news

ChatGPT in medicine: STAT answers readers' burning questions

Why did Pfizer dish out millions for a Super Bowl ad?

Jerome Adams on the need for new antivirals for Covid

Robert F. Kennedy is pitching centrism on health, even on abortion

Alkermes shareholders re

Hilary may become 1st tropical storm to make landfall in California in 84 years

knowledge

Cancer drug shortages' outsize impact on ovarian cancer patients

BioAge raises $170M for combination therapy with Zepbound

Liz Cheney makes 1st public comment since Trump's election interference indictments

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Senators start work on Medicare physician payment reform

Cancer drug shortages' outsize impact on ovarian cancer patients

leisure time

explore

knowledge

entertainment